A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas (Q47477264)
Jump to navigation
Jump to search
clinical trail researching phase III metastatic pancreatic cancer
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas |
clinical trail researching phase III metastatic pancreatic cancer |
Statements
March 2009
0 references
September 2012
0 references
861 people
0 references
18 years old
0 references
79 years old
0 references